Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Buying stock ahead of news with insider info. It will be hard to keep the news from leaking out of NYSE Mkt.
This is not a bear raid. It can also be manipulation to drop price so shorts can cover....another guess of mine.
The 10q was the last hurdle for uplisting. Maxim sold some converted warrants to drop the price so they can buy back in more at a lower level-my guess. Expect front running from market makers.
Notice one of the co-authors...Janet Woodcock....isn't she the head of the FDA?
Please refer to my post
Pvct will have the email but will wait for hard copy by regular mail to pr
During that time difference they will ask FDA for for clarifications on any detail if need be
Work on a pr
Have lawyers approve of pr
So we will not hear on the 23rd even if they know
FDA PR Company Policy
FDA will be emailing the answer
Pvct will not pr the answer until they have hard copy in their hands
To clarify
That answer is expected on the 23-24th
Pessimists.... Lol
Above $60
More additions to board of advisors
BTD PR Date
I have been informed that the login date at FDA was on the 24th of March and just to be cautious expect at or just after ASCO which puts it sometime first week of June due to unknown mailing times and time for the lawyers to approve pr wording.
They are being cautious and adding one week extra....makes sense if the FDA uses regular mail and sends it out on the 24th of May.
Over 25 patents not one.....plus the orphan drug status for two indications. One patent covers the possible patents PV-11 and PV-12 though the language is hard to read unless your a chemist. Which means this drug is covered and protected for decades.
For a single indication drug I would agree but the data out of cup, I hear, is showing multiple indications with great results.
If so, the drug is worth more.
Nobody here has talked to mgt of late about what they want for the company. That number hangs on the wall of the headquarters to remind them what they are working for and it is for a much larger number than any discussed in these posts....much larger. Four billion was a few years ago....
I would guess that when you see the 10q then uplisting not far behind.
Look for 10q first then be expecting uplisting
What is "missing" is the tumors
Yup
I love irony
Stay tuned
Possibility that four more of the top ten big pharmas coming on the BOA.....we will see.
But what do they know?...lol.
AZ tells Pfizer to go fly a kite....again.
Minimum share price is $2
Have big market maker/banker
Have enough money in the bank
Have enough shares and shareholders
Pass audit by NYSE, SEC, FINRA
All done.
Get fitted for a suit to ring the bell....pending...lol.
Yes that would be the logical time.
Pvct has a 10q coming in a week or so going by last years dates
Uplisting probably right after since it is safe to assume NYSE would require the latest to be filed
Yes
May should be big
As far as #12, that's too far off to read accurately
I could say three months or three years
Both could be equally correct
Personally I would like to see a btd on liver out of P1
It's possible and it makes end game worth more
$50 per share is still my goal
Mgt's number is higher
All depends on a bidding war and the resolve of shareholders to hold out for what it's really worth
Most institutions are not allowed to buy OTC stocks.
Some can only buy when stock is at $5 and others cannot buy unless stock is $10
New Order of Things
Based on current events and new info:
1. BTD Application-Done
2. NYSE Uplisting-Pending
3. New Board Members to BOA
4. BTD Granted
5. China Deal
6. India Deal
7. Month of May 2014 Ends
8. NDA
9. Big Pharma comes to the orphanage and picks us
10. Big bank sets fair market value
11. Other big pharmas come in and a bidding war starts
12. End Game
Sec filings out and 8k
Cantor Fitzgerald news and NYSE
Proxy vote form for upcoming meeting
Looks like proof for uplisting!!!
New Blog Post under news section....looks like somebody else hired the same firm last week.
Respect
Something that is hard to gain for this drug.
"It cures many types of cancer with no side effects?...bullshit!"
I have heard that a lot from people I talk to....actually most...and when I see them dismiss my conversation 30 seconds in, I want to punch them in the mouth....after all, they got their broker to do that research and everybody knows that they have the background to understand the science.....
Does it have respect from the decision makers of big pharmas who went another path and spent billions at a failing drug? They dare not say they missed this one.....they already look dumb enough. What about all those researchers who are tied up with other oncology drugs? They know which side their bread is buttered on. Peer reviewed journals.....ever hear their disdain for commercial scientists? The press? Those that spend millions and millions in advertising get the golden treatment.
So who does respect this drug? Moffit..yes...MD Anderson...the ones here who were not lazy and did their homework...the list is growing. When we get an uplisting and BTD then we will start getting the respect this drug deserves.
Why would it go down? China and India want to do a study anyway. Any BTD outcome besides a "NO" is awesome because it provides the clarity everybody wants. If we get uplisted before BTD we will start seeing a change of ownership from retail to institutional, after BTD even more of a change.
I think we will be just fine.
How many shares did you short?
Pfizer just wanted the tech and patents. A lot of people would have lost their jobs. AZ said to piss off. Talks are off.
Press on PVCT to Increase?
In talking to the Blogger I have been informed of some interesting activity. A major tv network has been spending a lot of time there along with some investment banks. If we get the uplisting like I am expecting, then expect all kinds of press. We have been waiting for institutional buying and we are likely going to start seeing that. Cantor expected to initiate coverage for starters.
Horrible....lol. But we are sitting on a royal flush....let the shorters fold.
There has always been a $30mm credit line with Lincoln that was never used and had a proportional number of shares reserved with it.
That line of credit will now be through Cantor Fitzgerald as they are the new market maker and investment banker. The credit line will go way way up and will be voted on in June at the annual meeting. It will never be used just like the other was never used....it is paperwork bs for uplisting.
Why the change?
Form D Filed
Requirement for something....hate to be short!
Cantor walked away from the bid today
They let it fall but not below $2
Although you may have been right
I suggest you cover
You can always short it another day
If your smart like I think you are
You will understand what I saw on level two today
Never know....NY is a dirty game.
Yup. They cannot make markets but they can work though another mm.